HK11489A - Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound - Google Patents

Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Info

Publication number
HK11489A
HK11489A HK114/89A HK11489A HK11489A HK 11489 A HK11489 A HK 11489A HK 114/89 A HK114/89 A HK 114/89A HK 11489 A HK11489 A HK 11489A HK 11489 A HK11489 A HK 11489A
Authority
HK
Hong Kong
Prior art keywords
tetrahydro
dihydroxy
hydroxyphenyl
beta
adrenergic blocking
Prior art date
Application number
HK114/89A
Other languages
English (en)
Inventor
Dennis Marvin Ackerman
Barry Alan Berkowitz
Virgil Daniel Wiebelhaus
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of HK11489A publication Critical patent/HK11489A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HK114/89A 1981-12-08 1989-02-09 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound HK11489A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81110252A EP0081006B1 (en) 1981-12-08 1981-12-08 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Publications (1)

Publication Number Publication Date
HK11489A true HK11489A (en) 1989-02-17

Family

ID=8188060

Family Applications (1)

Application Number Title Priority Date Filing Date
HK114/89A HK11489A (en) 1981-12-08 1989-02-09 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Country Status (18)

Country Link
US (1) US4469690A (enExample)
EP (1) EP0081006B1 (enExample)
JP (1) JPS58105921A (enExample)
AT (1) ATE15762T1 (enExample)
AU (1) AU550892B2 (enExample)
CA (1) CA1183777A (enExample)
DE (1) DE3172458D1 (enExample)
GR (1) GR77842B (enExample)
HK (1) HK11489A (enExample)
HU (1) HU187804B (enExample)
IL (1) IL67310A (enExample)
MY (1) MY8700934A (enExample)
NZ (1) NZ202510A (enExample)
PH (1) PH22073A (enExample)
PT (1) PT75915B (enExample)
SG (1) SG61188G (enExample)
ZA (1) ZA829004B (enExample)
ZW (1) ZW25482A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365134A1 (en) * 1988-09-16 1990-04-25 Smithkline Beecham Corporation Synergistic compositions of renal dopaminergic agent and angiotensin converting enzyme inhibitors
FI915717A7 (fi) * 1990-04-06 1991-12-04 Eisai Co Ltd Katekoliyhdistettä sisältävä kiinteä oraalinen valmiste
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
US4160765A (en) * 1976-11-17 1979-07-10 Smithkline Corporation Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4192297A (en) * 1978-05-25 1980-03-11 Leopold Labrecque Therapeutic feet bathing device
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
EP0022330B1 (en) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions

Also Published As

Publication number Publication date
MY8700934A (en) 1987-12-31
SG61188G (en) 1989-07-07
ZW25482A1 (en) 1983-02-23
IL67310A (en) 1988-09-30
EP0081006A1 (en) 1983-06-15
ZA829004B (en) 1983-09-28
ATE15762T1 (de) 1985-10-15
US4469690A (en) 1984-09-04
PH22073A (en) 1988-05-20
AU9084482A (en) 1983-06-16
CA1183777A (en) 1985-03-12
HU187804B (en) 1986-02-28
GR77842B (enExample) 1984-09-25
AU550892B2 (en) 1986-04-10
NZ202510A (en) 1985-09-13
PT75915A (en) 1982-12-01
JPS58105921A (ja) 1983-06-24
EP0081006B1 (en) 1985-09-25
DE3172458D1 (en) 1985-10-31
PT75915B (en) 1985-11-15

Similar Documents

Publication Publication Date Title
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
IE862554L (en) Pharmaceutical compositions
NO821586L (no) Fremgangsmaate til fremstilling av 1,2-diamino-cyklobuten-3,4-dioner.
DE3172458D1 (en) Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
ES515728A0 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
ES513138A0 (es) "procedimiento de preparacion de compuestos del tipo arilbencensulfonamida".
UA26442C2 (uk) Фармкомпозиція для профілактики і лікуваhhя захворюваhь, пов'язаhих з порушеhhям обміhу речовиh
ES510730A0 (es) "procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo".
IL72188A (en) 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
IT8621874A0 (it) Procedimento di preparazione di additivi surbasati molto fluidi e a basicita' elevata, e composizione contenente i detti additivi.
OA08630A (fr) Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.
ES512230A0 (es) "procedimiento de preparacion de derivados (7e,9z)-alcadienoles".
GR852224B (enExample)
ES516069A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
ES515801A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
ES509948A0 (es) "procedimiento para la preparacion de derivados de 2-oxa-biciclo (3.3.0) octano".
CA1263380C (en) MYCAMINOSYLTYLONOLIDE COMPOUNDS SUBSTITUTED FOR C-23 AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM
ES512940A0 (es) "procedimiento para la preparacion de colorantes azo-estilbenicos".
GR79114B (enExample)
AU8931082A (en) Xipamide and triamterene composition
ES512427A0 (es) "procedimiento para la preparacion de eteres difenilicos dotados de propiedades herbicidas".
ES512943A0 (es) "procedimiento para la preparacion de 3-metil-3(0-metoxifenoxi)-benzo-2,4-dioxaciclohexanona".